Cited 13 times in
Status of dyslipidemia management and statin undertreatment in Korean cancer survivors: A Korean National Health and Nutrition Examination Survey study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 정혜인 | - |
dc.date.accessioned | 2022-11-24T00:37:45Z | - |
dc.date.available | 2022-11-24T00:37:45Z | - |
dc.date.issued | 2021-08 | - |
dc.identifier.issn | 2047-4873 | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/190833 | - |
dc.description.abstract | Aims: Due to improving cancer treatment results, non-cancer mortality is an important issue for cancer survivors. Cardiovascular diseases are the leading causes of death in Korea and globally. In addition to lowering the risk of cardiovascular disease, the use of statins has led to an overall reduction in cancer mortality in recent observational studies. We investigated the status of current dyslipidemia management in cancer survivors with reference to 2018 guidelines. Methods: The study is a cross-sectional analysis of 1460 cancer survivors aged from 40 to 75 years who participated in the Korean National Health and Nutrition Examination Survey from 2007 to 2016. Dyslipidemia management status among cancer survivors was assessed according to 2018 American College of Cardiology/American Heart Association guidelines and Korean Coronary Heart Disease Risk Score guidelines. Results: The rate of treatment for dyslipidemia was 8.5% for males, 13.8% for females, and 11.9% overall. Among cancer survivors who were not receiving treatment for dyslipidemia, 59.6% of males, 34.2% of females and 43.9% of total cancer survivors would have been eligible for statin therapy under the 2018 American College of Cardiology/American Heart Association guidelines and Korean Coronary Heart Disease Risk Score guidelines. The rate of undertreatment of dyslipidemia increased with age and length of time since cancer diagnosis. Conclusion: Nearly 50% of cancer survivors remain untreated although they are eligible for statin therapy. This emphasizes the need for more attention to prevent atherosclerotic cardiovascular disease among cancer survivors. | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | Sage | - |
dc.relation.isPartOf | EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.subject.MESH | Cancer Survivors* | - |
dc.subject.MESH | Cardiovascular Diseases* / diagnosis | - |
dc.subject.MESH | Cardiovascular Diseases* / epidemiology | - |
dc.subject.MESH | Cardiovascular Diseases* / prevention & control | - |
dc.subject.MESH | Cross-Sectional Studies | - |
dc.subject.MESH | Dyslipidemias* / diagnosis | - |
dc.subject.MESH | Dyslipidemias* / drug therapy | - |
dc.subject.MESH | Dyslipidemias* / epidemiology | - |
dc.subject.MESH | Female | - |
dc.subject.MESH | Humans | - |
dc.subject.MESH | Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use | - |
dc.subject.MESH | Male | - |
dc.subject.MESH | Neoplasms* / diagnosis | - |
dc.subject.MESH | Neoplasms* / drug therapy | - |
dc.subject.MESH | Neoplasms* / epidemiology | - |
dc.subject.MESH | Nutrition Surveys | - |
dc.subject.MESH | Republic of Korea / epidemiology | - |
dc.subject.MESH | United States | - |
dc.title | Status of dyslipidemia management and statin undertreatment in Korean cancer survivors: A Korean National Health and Nutrition Examination Survey study | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Sujeong Shin | - |
dc.contributor.googleauthor | Dong Wook Shin | - |
dc.contributor.googleauthor | In Young Cho | - |
dc.contributor.googleauthor | Su-Min Jeong | - |
dc.contributor.googleauthor | Hyein Jung | - |
dc.identifier.doi | 10.1177/2047487320905722 | - |
dc.contributor.localId | A05780 | - |
dc.relation.journalcode | J00843 | - |
dc.identifier.eissn | 2047-4881 | - |
dc.identifier.pmid | 34298552 | - |
dc.identifier.url | https://academic.oup.com/eurjpc/article/28/8/864/6327102 | - |
dc.subject.keyword | Cancer survivors | - |
dc.subject.keyword | cardiovascular disease | - |
dc.subject.keyword | dyslipidemia | - |
dc.subject.keyword | prevention | - |
dc.contributor.alternativeName | Jung, Hyein | - |
dc.contributor.affiliatedAuthor | 정혜인 | - |
dc.citation.volume | 28 | - |
dc.citation.number | 8 | - |
dc.citation.startPage | 864 | - |
dc.citation.endPage | 872 | - |
dc.identifier.bibliographicCitation | EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, Vol.28(8) : 864-872, 2021-08 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.